The medical device industry is constantly looking for innovative new ways to treat and cure conditions. Last month, the FDA permitted marketing of the first-ever game-based digital therapeutic device aimed at treating children with attention deficit hyperactivity disorder (ADHD). The prescription-only video game, in combination with other treatments, is engineered to create physiological changes in the brain to improve cognitive function...
FDA’s Digital Software Pre-Certification ProgramEMMAIntl
The digital health software precertification program is FDA’s strong footstep in leading the way to support the inclusion of the digital world in the US healthcare industry. As part of FDA’s digital health innovation action plan, the pre-cert program was announced in July 2017, and since then has gained tremendous acceptance by the industry...
mHealth Israel_Levi Shapiro_Israel Digital Health Overview Levi Shapiro
Overview of digital health investment sector, including investment, funding and exit trends in the US and Israel, as well as successful case studies of eHealth companies in the US and Israel
HxRefactored 2015: Drew Schiller "Beyond the Bracelet"HxRefactored
Drew Schiller, Co-founder & CTO of Validic discusses changes in healthcare as a result of the wearable movement which enables patients to take a more active role in their own healthcare.
AI in Healthcare | Future of Smart Hospitals Renee Yao
In this talk, I specifically talk about how NVIDIA healthcare AI software and hardware were used to support healthcare AI startups' innovation. Three startups featured: Caption Health, Artisight, and Hyperfine. Audience: healthcare systems CXOs.
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...HxRefactored
Through new telehealth technologies and increased data analysis physicians are gaining insights into patients like never before, allowing them to facilitate early interventions, improve adherence, and reduce readmission rates -- not to mention at a price more affordable than ever. The companies you’ll hear from in this session are using a healthy and innovative mix of data, educational tools, sensors, and more to improve patient outcomes.
Embracing game-changing trends and innovations across telehealth, SDOH data integration, AI and gene editing is a great way to build on a promise of a better tomorrow. Go through this presentation to know the top healthcare trends to embrace in 2021.
FDA’s Digital Software Pre-Certification ProgramEMMAIntl
The digital health software precertification program is FDA’s strong footstep in leading the way to support the inclusion of the digital world in the US healthcare industry. As part of FDA’s digital health innovation action plan, the pre-cert program was announced in July 2017, and since then has gained tremendous acceptance by the industry...
mHealth Israel_Levi Shapiro_Israel Digital Health Overview Levi Shapiro
Overview of digital health investment sector, including investment, funding and exit trends in the US and Israel, as well as successful case studies of eHealth companies in the US and Israel
HxRefactored 2015: Drew Schiller "Beyond the Bracelet"HxRefactored
Drew Schiller, Co-founder & CTO of Validic discusses changes in healthcare as a result of the wearable movement which enables patients to take a more active role in their own healthcare.
AI in Healthcare | Future of Smart Hospitals Renee Yao
In this talk, I specifically talk about how NVIDIA healthcare AI software and hardware were used to support healthcare AI startups' innovation. Three startups featured: Caption Health, Artisight, and Hyperfine. Audience: healthcare systems CXOs.
HXR 2016: The Health IoT: Remote Care and Mobile Solutions -Andrew Hooge, Val...HxRefactored
Through new telehealth technologies and increased data analysis physicians are gaining insights into patients like never before, allowing them to facilitate early interventions, improve adherence, and reduce readmission rates -- not to mention at a price more affordable than ever. The companies you’ll hear from in this session are using a healthy and innovative mix of data, educational tools, sensors, and more to improve patient outcomes.
Embracing game-changing trends and innovations across telehealth, SDOH data integration, AI and gene editing is a great way to build on a promise of a better tomorrow. Go through this presentation to know the top healthcare trends to embrace in 2021.
HXR 2016: Improving Insurance Member Experiences -Christopher NeuharthHxRefactored
This section of the agenda will feature leaders in innovation, customer experience, and design within the health insurance space. Each panelist will present the current state of experience at their organization, what successes they have seen, what situations they have learned from, and what their challenges and obstacles are, and where they would like to see things head in the future. Then Amy Cueva will guide the group in a discussion around strategy, measurement, culture change, and other important topics relevant to delivering phenomenal experiences.
On June 6th, FDA approved a continuous glucose monitoring device through the PMA pathway. This device has the ability to continually monitor blood glucose levels for 90 days sending the data through Bluetooth to the connected smart device(s)...
Producing Better and Affordable Healthcare Services Using Computational Intel...EMMAIntl
Computational Intelligence (CI) is one of the major pillars of Artificial Intelligence. It is the study, design, and development of intelligent software based on the theory of evolution. Within the past decade, healthcare has become expensive. Also, with the declining doctor-patient ratio, there are constant needs for computing systems for everything from executing simple tasks, such as booking appointments, to major services such as consulting and diagnosis...
Extending the Case for Digital: Health Plan Members SpeakCognizant
Cognizant's exclusive study shows that healthcare consumers’ appetite for digital continues to expand and deepen across all channels and age ranges: 10 key findings that will help health plans refine their digital member experience strategies in 2018 and beyond.
At RavenTek, we help healthcare providers secure what matters most, build organizational resilience against cyberattacks and maximize provider Return On Life. We combine world-class technologies, innovative security ideas and a forward-thinking team of problem solvers and consultants to secure healthcare providers. We believe enterprise visibility and persistent, always-on security testing is the essential foundation of every cybersecurity program.
Ryan Coleman is Vice President of Healthcare Cybersecurity at RavenTek.
Quality Systems and Good Machine Learning PracticesEMMAIntl
FDA expects every medical device manufacturer to have a robust and compliant quality system. FDA has been taking great strides in establishing regulations for the digital health industry that also facilitates research and development while maintaining high quality products...
C19: Respond, recover & reimagine the future of HCP engagementAcross Health
And Across Health responded in an agile way to the C19 disruption: we've taken important steps in optimizing the Navigator ecosystem, with over 6,000 HCP respondents since June, insightful COVID-19 questions, new Powertools, upgrades to our integrated OCE Planner Pro, the launch of a DIY “starterkit”, a new OCE capability-boosting platform (SCALA), etc.
Our webinar will take you through the latest Navigator 365 insights, demo the newest Powertools, and show how the data can be used for evidence-based omnichannel HCP journey planning, orchestration, measurement - and ongoing optimization.
Watch the recorded webinar on our website: https://bit.ly/2UmkvcU.
2 years in 2 months? Digital acceleration in biopharmaAcross Health
Relive Across Health first iD.cast: 90 minutes of inspiration on digital acceleration in biopharma
Get food and facts for thought on how biopharma companies can embrace the COVID-19 wake-up call and turn these disruptive times into an opportunity for hyper-acceleration and re-invention. The session featured two highly engaging speakers – and scored an NPS of 65!
- Peter Hinssen, Co-founder Nexxworks, serial entrepreneur, best-selling author, and thought leader on digitalization & innovation
The "VACINE" for the Never Normal and the hourglass model for corporate innovation
- Fonny Schenck, CEO Across Health
2 years in 2 months? Digital acceleration in biopharma
Watch the recorded webinar or download the slides to learn how to be the Phoenix in the biopharma world and create a sustainable competitive superiority: https://bit.ly/2IZDDLv.
Healthcare in Digital Age
by Assit. Prof. Polawat Witoolkollachit,MD
Present for the 3rd Samitivej Sriracha Medical Symposium 2018 "CQI & Innovation in Healthcare 4.0"
mHealth Israel_Future of Integrated Individualized Healthcare_Roche DiagnosticsLevi Shapiro
Presentation by Alexandra Eberhard, Sr. Director, Global Business Development, Roche Diagnostics on the "Future of Integrated Individualized Healthcare". Includes background about Roche Diagnostics and investments in innovation. Overview of Roche products and solutions with a portfolio covering the entire spectrum of diagnostics users. Emphasis on the triple aim of healthcare- The power of data and technology to enable the transformation from volume- to value-based healthcare. Interest in data for Pharma - drive more efficient R&D; DIA - develop novel patient care Dx solutions. Focus on the needs of labs, physicians & payers for better patient health. A suite of digital solutions that improve clinical & business outcomes. Suite of solutions to optimize the lab. Translating data into insights to achieve financial goals. A move from volume- to value-based care. New opportunities in the disease continuum- Holistic solutions approach. Expanding the focus towards earlier in the patient journey. Doing now what patients need next. Contact Alexandra Vallon-Eberhard, PhD MBA; Sr. Director Global Business Development; Diagnostics Lead for Innovation in Israel; Based in Basel, Switzerland; Email: alexandra.vallon_eberhard@roche.com
Healthcare Rx: The Rise of the Empowered ConsumerCognizant
Market and digital forces have combined to enable the healthcare industry to treat much of what ails it — or be supplanted by newcomers who can more quickly seize the digital high ground.
AXA Europe- Unlocking value from digital healthLevi Shapiro
Unlocking value from digital health, presentation for mHealth Israel, May 19th, 2021, by Somesh Chandra – Chief Health Officer, European Markets, AXA Group. Health expenditure has outpaced economic growth, raising sustainability concerns. Barriers to access persist, particularly amongst the less well-off. Digital health services expected to grow at 21.8% CAGR from 2020-2030, adoption accelerated due to COVID-19 pandemic. 90% of the world's data has been created in the past 2 years. AXA-Microsoft Partnership – Launch of the Digital Healthcare Platform. AXA’s ambition is to be at the heart of the Health Ecosystem to meet customer demands in this new normal world. This Digital Health Orchestration requires close collaboration with all players (services providers, insurers,
companies, regulators etc.) of the health industry. AXA Italy Case Study – An integrated, outcome based and personalized journey focussed on solving customer’s health problems. Portal is already live! Solution is live & supporting customers to solve
their health needs in Italy & Germany.
HXR 2016: Free the Data Access & Integration -Jonathan Hare, WebShieldHxRefactored
Utilizing the power of data can empower patients and arm developers in the creation of new tools and platforms. Whether it’s authenticating data, downloading it via BlueButton, or connecting data with other applications using BlueButton on FHIR, increased data accessibility is a win for everyone. Presenters will give an overview of the opportunities and challenges that exist today and share the newest technologies and initiatives that are overcoming them.
Rethinking Health Plan Business Models for the Emerging On-Demand Digital Eco...Cognizant
Even as on-demand healthcare platforms disrupt the industry, they create possibilities for new value propositions, partnerships and business models that will further reshape the cost and delivery of care.
The FDA Digital Health Center of Excellence and the Advancement of Digital He...Greenlight Guru
The FDA Digital Health Center of Excellence is part of the planned evolution of the digital health program with the intent to drive synergy for digital health efforts, align strategy with implementation, prepare the FDA for the digital health future, and protect patients and maintain the FDA standards of safety and effectiveness.
Ultimately, the program works to strategically advance science and evidence for digital health technologies that meets the needs of
stakeholders.
This free in-depth webinar, presented by Matthew DiamondChief Medical Officer, Digital Health Center of Excellence, will cover the digital health landscape and areas of application, goals and outcomes, planned services and launch plan, and the current areas of focus - including AI/ML-Based SaMD.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
Digital Therapeutics Regulatory Process, Update and TrendsInsights10
The market for digital therapeutics (DTx) is expanding tremendously, aided by the increased popularity of decentralized medicine that the pandemic brought about. The global market for DTx was predicted to be worth $3.35 billion in 2021 and would grow to $12.1 billion by 2026. To get a report in detail, contact us at - info@insights10.com
HXR 2016: Improving Insurance Member Experiences -Christopher NeuharthHxRefactored
This section of the agenda will feature leaders in innovation, customer experience, and design within the health insurance space. Each panelist will present the current state of experience at their organization, what successes they have seen, what situations they have learned from, and what their challenges and obstacles are, and where they would like to see things head in the future. Then Amy Cueva will guide the group in a discussion around strategy, measurement, culture change, and other important topics relevant to delivering phenomenal experiences.
On June 6th, FDA approved a continuous glucose monitoring device through the PMA pathway. This device has the ability to continually monitor blood glucose levels for 90 days sending the data through Bluetooth to the connected smart device(s)...
Producing Better and Affordable Healthcare Services Using Computational Intel...EMMAIntl
Computational Intelligence (CI) is one of the major pillars of Artificial Intelligence. It is the study, design, and development of intelligent software based on the theory of evolution. Within the past decade, healthcare has become expensive. Also, with the declining doctor-patient ratio, there are constant needs for computing systems for everything from executing simple tasks, such as booking appointments, to major services such as consulting and diagnosis...
Extending the Case for Digital: Health Plan Members SpeakCognizant
Cognizant's exclusive study shows that healthcare consumers’ appetite for digital continues to expand and deepen across all channels and age ranges: 10 key findings that will help health plans refine their digital member experience strategies in 2018 and beyond.
At RavenTek, we help healthcare providers secure what matters most, build organizational resilience against cyberattacks and maximize provider Return On Life. We combine world-class technologies, innovative security ideas and a forward-thinking team of problem solvers and consultants to secure healthcare providers. We believe enterprise visibility and persistent, always-on security testing is the essential foundation of every cybersecurity program.
Ryan Coleman is Vice President of Healthcare Cybersecurity at RavenTek.
Quality Systems and Good Machine Learning PracticesEMMAIntl
FDA expects every medical device manufacturer to have a robust and compliant quality system. FDA has been taking great strides in establishing regulations for the digital health industry that also facilitates research and development while maintaining high quality products...
C19: Respond, recover & reimagine the future of HCP engagementAcross Health
And Across Health responded in an agile way to the C19 disruption: we've taken important steps in optimizing the Navigator ecosystem, with over 6,000 HCP respondents since June, insightful COVID-19 questions, new Powertools, upgrades to our integrated OCE Planner Pro, the launch of a DIY “starterkit”, a new OCE capability-boosting platform (SCALA), etc.
Our webinar will take you through the latest Navigator 365 insights, demo the newest Powertools, and show how the data can be used for evidence-based omnichannel HCP journey planning, orchestration, measurement - and ongoing optimization.
Watch the recorded webinar on our website: https://bit.ly/2UmkvcU.
2 years in 2 months? Digital acceleration in biopharmaAcross Health
Relive Across Health first iD.cast: 90 minutes of inspiration on digital acceleration in biopharma
Get food and facts for thought on how biopharma companies can embrace the COVID-19 wake-up call and turn these disruptive times into an opportunity for hyper-acceleration and re-invention. The session featured two highly engaging speakers – and scored an NPS of 65!
- Peter Hinssen, Co-founder Nexxworks, serial entrepreneur, best-selling author, and thought leader on digitalization & innovation
The "VACINE" for the Never Normal and the hourglass model for corporate innovation
- Fonny Schenck, CEO Across Health
2 years in 2 months? Digital acceleration in biopharma
Watch the recorded webinar or download the slides to learn how to be the Phoenix in the biopharma world and create a sustainable competitive superiority: https://bit.ly/2IZDDLv.
Healthcare in Digital Age
by Assit. Prof. Polawat Witoolkollachit,MD
Present for the 3rd Samitivej Sriracha Medical Symposium 2018 "CQI & Innovation in Healthcare 4.0"
mHealth Israel_Future of Integrated Individualized Healthcare_Roche DiagnosticsLevi Shapiro
Presentation by Alexandra Eberhard, Sr. Director, Global Business Development, Roche Diagnostics on the "Future of Integrated Individualized Healthcare". Includes background about Roche Diagnostics and investments in innovation. Overview of Roche products and solutions with a portfolio covering the entire spectrum of diagnostics users. Emphasis on the triple aim of healthcare- The power of data and technology to enable the transformation from volume- to value-based healthcare. Interest in data for Pharma - drive more efficient R&D; DIA - develop novel patient care Dx solutions. Focus on the needs of labs, physicians & payers for better patient health. A suite of digital solutions that improve clinical & business outcomes. Suite of solutions to optimize the lab. Translating data into insights to achieve financial goals. A move from volume- to value-based care. New opportunities in the disease continuum- Holistic solutions approach. Expanding the focus towards earlier in the patient journey. Doing now what patients need next. Contact Alexandra Vallon-Eberhard, PhD MBA; Sr. Director Global Business Development; Diagnostics Lead for Innovation in Israel; Based in Basel, Switzerland; Email: alexandra.vallon_eberhard@roche.com
Healthcare Rx: The Rise of the Empowered ConsumerCognizant
Market and digital forces have combined to enable the healthcare industry to treat much of what ails it — or be supplanted by newcomers who can more quickly seize the digital high ground.
AXA Europe- Unlocking value from digital healthLevi Shapiro
Unlocking value from digital health, presentation for mHealth Israel, May 19th, 2021, by Somesh Chandra – Chief Health Officer, European Markets, AXA Group. Health expenditure has outpaced economic growth, raising sustainability concerns. Barriers to access persist, particularly amongst the less well-off. Digital health services expected to grow at 21.8% CAGR from 2020-2030, adoption accelerated due to COVID-19 pandemic. 90% of the world's data has been created in the past 2 years. AXA-Microsoft Partnership – Launch of the Digital Healthcare Platform. AXA’s ambition is to be at the heart of the Health Ecosystem to meet customer demands in this new normal world. This Digital Health Orchestration requires close collaboration with all players (services providers, insurers,
companies, regulators etc.) of the health industry. AXA Italy Case Study – An integrated, outcome based and personalized journey focussed on solving customer’s health problems. Portal is already live! Solution is live & supporting customers to solve
their health needs in Italy & Germany.
HXR 2016: Free the Data Access & Integration -Jonathan Hare, WebShieldHxRefactored
Utilizing the power of data can empower patients and arm developers in the creation of new tools and platforms. Whether it’s authenticating data, downloading it via BlueButton, or connecting data with other applications using BlueButton on FHIR, increased data accessibility is a win for everyone. Presenters will give an overview of the opportunities and challenges that exist today and share the newest technologies and initiatives that are overcoming them.
Rethinking Health Plan Business Models for the Emerging On-Demand Digital Eco...Cognizant
Even as on-demand healthcare platforms disrupt the industry, they create possibilities for new value propositions, partnerships and business models that will further reshape the cost and delivery of care.
The FDA Digital Health Center of Excellence and the Advancement of Digital He...Greenlight Guru
The FDA Digital Health Center of Excellence is part of the planned evolution of the digital health program with the intent to drive synergy for digital health efforts, align strategy with implementation, prepare the FDA for the digital health future, and protect patients and maintain the FDA standards of safety and effectiveness.
Ultimately, the program works to strategically advance science and evidence for digital health technologies that meets the needs of
stakeholders.
This free in-depth webinar, presented by Matthew DiamondChief Medical Officer, Digital Health Center of Excellence, will cover the digital health landscape and areas of application, goals and outcomes, planned services and launch plan, and the current areas of focus - including AI/ML-Based SaMD.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
Digital Therapeutics Regulatory Process, Update and TrendsInsights10
The market for digital therapeutics (DTx) is expanding tremendously, aided by the increased popularity of decentralized medicine that the pandemic brought about. The global market for DTx was predicted to be worth $3.35 billion in 2021 and would grow to $12.1 billion by 2026. To get a report in detail, contact us at - info@insights10.com
Digital Medicine: Integrating Pharma and Med DevicesEMMAIntl
With the recent pandemic, one of the most crucial medical services is that of Digital Medicine. It is the merger of the medical device, pharma industries, and modern technology to better track and understand the physiological systems along with the generation of analytics based on the continuously growing patient data sets...
RapidValue White Paper on Regulations and compliance for enterprise mHealth a...Nageena Vijayan
Healthcare organizations and software firms looking to make investments in mobile applications need to assess implications of HIPAA and FDA in order to protect patient health information and
ensure compliances are met. This document outlines some of the key evaluation criteria on regulations and security considerations in healthcare sector that need to be addressed while
implementing mobility applications.
Development Standards and Regulations for HealthTechElinext
Wearables, surgery robots, wellness platforms, and digital doctors. The new healthcare landscape is bright, full of novelties and breaking ideas. But before entering this market, you should learn the basic regulations and standards for HealthTech products. We gathered all the information for you in our new infographic.
Digital Therapeutics regulations in US, EU and JapanGargiVaghela
This PowerPoint presentation provides a comprehensive overview of the current regulatory landscape governing digital therapeutics in the United States, European Union, and Japan, offering valuable insights on the regulatory perspective of DTx.
The effects of COVID-19 have been widespread across different parts of the medical device world, but the Digital Health sector has seen the most growth because of the pandemic. The scope of digital health includes mobile health, health information technology, wearable devices, and telehealth/telemedicine. As the world looks for ways to migrate normal life to “social-distance” life, Digital Health provides the ability for healthcare providers and patients to connect quickly, effectively, and remotely...
NEST – Improving the Regulatory Process for Medical DevicesEMMAIntl
Innovating the medical device regulatory process is a goal that the FDA’s Center for Devices and Radiological Health (CDRH) is constantly striving towards. Among several other programs introduced or changed over the past couple years, the National Evaluation System for Health Technology (NEST) is a program the FDA is building upon to generate better real-world evidence to guide their decision-making around medical devices...
WNS offers healthcare provider solutions that bends the cost curve and improve business outcomes with high profitability. Learn More at https://www.wns.com/industries/healthcare/provider
WNS offers Healthcare Payer services to enhance patient care, reduce costs and optimize provider collaboration. Read more about our Healthcare Payer BPO services now. Learn More Visit :- https://www.wns.com/industries/healthcare/payer
WNS' digital-first, patient-centric healthcare BPO services enable companies to outperform their peers. Learn how our healthcare outsourcing and BPM services can transform your business. Learn More at https://www.wns.com/industries/healthcare
Regulatory Considerations in Mobile ProgramsDale Cooke
This presentation looks at some of the unique considerations in developing mobile programs, especially mobile apps. A significant amount of the presentation is dedicated to elucidating and expanding on the FDA's recently finalized guidance regarding mobile medical apps. Topics covered include:
* FDA’s finalized Mobile Medical Applications—Guidance for Industry and Food and Drug Administration Staff
* Determination of whether a mobile app is a medical device subject to FDA enforcement action
* Scope of FDA’s regulatory discretion regarding mobile apps
* FDA’s conflicting guidance on dosage apps
* How to meet key requirements of promotional labeling in mobile programs
* The growing area of mobile apps as promotional messaging platforms
This presentation has appeal for anyone interested in adopting mobile tactics, whether that interest is in developing medical devices or making use of mobile tactics to promote pharmaceuticals or biologics.
The framework flow chart shown in this presentation is available here: http://ow.ly/qMxse
On September 24, 2013, the U.S. Food and Drug Administration announced the new requirement to identify medical devices that affect its safe and effective use through the use of UDI. Explore on how Freyr can help medical device companies achieve UDI compliance.
Many attempts have been made to produce a long-term, cost-effective, and biocompatible scaffold; however, most attempts fail to achieve this. An example would be collagen-based scaffolds. Collagen is the body’s most abundant protein and is thus highly biocompatible. Unfortunately, collagen-based scaffolds have disappointing long-term properties including poor shape retention and mechanical strength. Many types of these bio-scaffolds exist including protein-based, carbohydrate-based, polymer-based, or a combination of these...
Stability Testing of Pharmaceuticals and SupplementsEMMAIntl
Whether you are working on a prescription drug, over-the-counter (OTC) drug, or even a dietary supplement, stability testing is required depending on the location of registration and agencies involved in its approval. Stability testing is the method of testing a product's safety, efficacy, and chemical composition after a set period...
Millions in the United States alone have an allergic condition, with many of these allergies being related to food. According to the Food Allergy Research & Education organization (FARE) 32 million Americans have food allergies. Of those 32 million, 200,000 require emergency medical care for allergic reactions from those foods. A common misconception is that food intolerance is a food allergy when in actuality that is its own unique category...
The field of biomedical engineering is a new, widely researched, and well-funded industry that aims to tackle problems in medicine and health by providing engineered solutions. These solutions might be delivered in the form of electrical hardware, chemicals, or even software. Given the extensive range of applications that exist in the medical device industry, the field is continuously accelerating its innovations in technology via an abundance of research and innovation outlets in countless interrelated fields. One of the many fields that are fundamentally fueling the growth of the biomedical industry is material science...
Investigating Ketamine for Parkinson’s DiseaseEMMAIntl
In May 2021, the FDA approved an Investigational New Drug (IND) application from PharmaTher Holdings Ltd., to proceed with a Phase Two clinical trial. PharmaTher Holdings Ltd. is a psychedelics biotech organization that focuses on research and development, and commercialization of psychedelics to treat pain and neurological disorders, and mental illnesses. This company is headquartered in Vancouver, Canada...
Aduhelm, an Accelerated Approval for Alzheimer’sEMMAIntl
Alzheimer’s disease is the most common cause of dementia, especially in patients aged 65 and older1. Alzheimer’s disease is a neurodegenerative disease that has a direct correlation to age: as age increases, the likelihood of developing Alzheimer’s increases as well. Alzheimer’s has long been a subject of discussion in the pharmaceutical industries and, until the FDA’s recent accelerated approval of Aduhelm earlier this month, the most recent treatment approved for Alzheimer’s was in 2003, almost two decades ago. The FDA’s approval of Aduhelm represents the first-of-its-kind treatment and is the first therapy that aims to interrupt the underlying physiological pathway of Alzheimer’s, rather than simply attempt to treat its symptoms...
Every June 14th, the World Health Organization (WHO) hosts World Blood Donor Day to raise awareness all over the globe for how crucial the need for safe blood is in the healthcare industry. In the US and Canada alone, 43,000 pints of blood are used each day for life-saving procedures and treatments...
Starting in Summer 2021, a new type of COVID vaccine could be available. Known as a protein subunit vaccine, this vaccine contains a spike protein that the other three vaccines are missing. The other vaccines, Pfizer, Moderna, and Johnson & Johnson, contain instructions for the spike protein but do not actually include the spike protein in the vaccination. The three vaccines allow our cell bodies to make the protein up for itself...
June 14th through the 20th is Men’s Health Week, which is a great opportunity to heighten awareness for men’s depression. There is a theme in society applicable to most men as they tend to internalize depressive thoughts, not allowing for a proper diagnosis. There are four major reasons men do not reach out for help with their depression: failure to recognize the depression consuming them, downplaying signs and symptoms, reluctance to converse about their feelings with others, and resisting mental health treatment...
Celebrating Pride Month at EMMA InternationalEMMAIntl
June 1 started the celebration of Pride Month, which commemorates Lesbian, Gay, Bisexual, and Transgender members. Celebrating Pride Month is also more than celebrating members of the LGBTQIA+, this month is also about recognizing that diversity fuels innovation and collaboration among a variety of industries, including the life sciences...
Growth and Integration of ML/AI in BiotechEMMAIntl
The biotechnology and pharmaceutical industries are heavily reliant on collecting, storing, and analyzing data for both R&D as well as production purposes. The large, countless, and rapidly growing sets of data are critical for researchers and scientists to accelerate progress in the medical industry. As our technologies advance and our capacity to store data continue to increase, we must continue to find new ways to efficiently analyze data. Researchers at the European Bioinformatics Institute (EMBL-EBI) have determined that nucleotide and proteomics data is growing at an exponential rate, with the amount of data stored on their servers doubling each year...
Quality Function Deployment, or QFD, is a decades-old methodology focused on the voice of the customer. It was initially developed in Japan in the 1960s but was popularized in the US by the automotive industry in the 1980s . QFD is a tool often leveraged by Total Quality Management (TQM), which is a quality principle that customers define quality and subsequently should be prioritized at all stages of the product, both pre-and post-production...
New digital health technology is coming out every day and is changing the course of the MedTech industry as we know it. Many physicians are making the transition to using these digital health devices and technologies to improve patient care and outcomes. Some of this increase can be attributed to COVID-19 of course as it enabled them to provide care for patients remotely. However, many of these digital health devices and technologies have been around for a bit, so what caused the hesitation in adapting them sooner and what are some of the great perks of this new wave of medical care?
Immune Systems After the COVID-19 PandemicEMMAIntl
Everyone has heard that immune systems weaken when they are sheltered, but is that really the case? As we are now over one year into lockdowns and social distancing, many are becoming concerned that after the pandemic immune systems are going to falter after being isolated for such a long period, and many adults are concerned to resume a “normal” life due to this...
Stability Testing Requirements for PharmaceuticalsEMMAIntl
Deciding how and when to conduct stability tests on your new drug can be challenging. Stability tests provide evidence data on how the quality of a drug substance or drug product varies with time under the influence of a variety of environmental factors. It also establishes a retest period for the drug substance or a shelf life for the drug product and recommended storage conditions...
EMMA International is continuing to celebrate Women’s Health Week! While there are so many reasons Women’s Health Week is important, one of the best things to come out of this week is the attention it brings and the reminders that we should all consider our health and take steps to ensure a healthy future...
Happy National Women’s Health Week! In honor of this week bringing light to important women’s health issues, I wanted to walk through a brief history of innovations that shaped one of the largest facets of women’s health – reproductive health...
In the work from home era, we all realized how important it is to digitize our important documents and what a lifesaver digital signatures are. With everything now getting electronically stored, electronic signatures and documentation are slowly replacing the paper-based system. That means we must now get ready to expand our digital storage plans rather than buying new filing cabinets...
Considerations for Biocompatibility EvaluationEMMAIntl
Biocompatibility is one of the most critical performance studies that manufacturers need to perform as part of their product development process. ISO 10993-5 and ISO 10993-10 are FDA-recognized standards for biocompatibility. Whether you perform these studies in-house or send out samples to a third-party lab the protocol for biocompatibility assessment must be conducted in accordance with ISO 10993...
Restoring the Earth for a Healthier FutureEMMAIntl
Today marks the 52nd anniversary of the birth of the true modern environmental movement, however, you probably know it as Earth Day. Early in the pandemic, many hoped that the lockdowns would help the Earth heal as people began to stay home, stopped commuting, and some factories even had paused production. Unfortunately, as things are beginning to open back up emissions are on the rise again and we need to continue to think about the future consequences...
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Telehealth Psychology Building Trust with Clients.pptx
FDA and Digital Therapeutics
1. FDA and Digital Therapeutics
By: Madison Wheeler
The medical device industry is constantly looking for innovative new ways to treat and cure
conditions. Last month, the FDA permitted marketing of the first-ever game-based digital
therapeutic device aimed at treating children with attention deficit hyperactivity disorder
(ADHD). The prescription-only video game, in combination with other treatments, is
engineered to create physiological changes in the brain to improve cognitive function.1
EndeavorRx, the name of the game-based device, is the latest example in the growing field of
digital therapeutics.
Digital therapeutics and digital therapies like EndeavorRx are a part of the broad scope of
Digital Health. As innovative new medical device technology is rapidly engineered, the FDA has
established the Digital Health Innovation Action Plan. This plan documents the FDA’s
commitment to several key goals in regards to digital health: Issuing guidance to modernize
policies, increasing the number and expertise of digital health staff at the FDA, and developing
the Digital Health Software Precertification Pilot Program.2 This software precertification
program, also known as the Software Pre-Cert Program, is the foundation of developing a
regulatory model that will provide streamlined and efficient regulatory oversight of software-
based medical devices.3 Through the pre-cert program, software companies can become pre-
certified and would accordingly benefit from a streamlined premarket review process.
EndeavorRx was reviewed through the De Novo premarket review pathway, and its approval
creates a new regulatory classification. With the regulatory classification created, it opens the
door for subsequent devices with the same intended use to follow the 510(k) premarket
notification process and obtain marketing authorization if they demonstrate substantial
equivalence.4 As more ground-breaking digital therapeutics are cleared through the FDA, and
more regulatory classifications are created, consumers can expect to see more of these
innovative devices in the market.
If you are a software company developing a medical device and need regulatory guidance,
EMMA International has the expertise to help. Call 248-987-4497 or email
info@emmainternational.com to get connected with our team of regulatory experts today.
1 Akili Interactive(n.d.) Science & Technology retrieved on 07/05/2020 from:
https://www.akiliinteractive.com/science-and-technology
2 FDA (June 2020) Digital Health retrieved on 07/05/2020 from: https://www.fda.gov/medical-devices/digital-
health
3 FDA (July 2019) Digital Health Software Precertification (Pre-Cert) Programretrieved on 07/05/2020 from:
https://www.fda.gov/medical-devices/digital-health/digital-health-software-precertification-pre-cert-program
4 FDA (June 2020) FDA Permits Marketing of FirstGame-Based Digital Therapeutic to Improve Attention Function in
Children with ADHD retrieved on 07/05/2020 from: https://www.fda.gov/news-events/press-announcements/fda-
permits-marketing-first-game-based-digital-therapeutic-improve-attention-function-children-adhd